Pasithea Therapeutics Corp. (KTTAW) Divestments (2022 - 2023)
Pasithea Therapeutics' (KTTAW) quarterly Divestments came in at $319618.0 in Q2 2023, up 173.94% year-over-year from $116676.2 in Q2 2022, and up 7529.94% quarter-over-quarter from $4189.0 in Q1 2023.
Powered by 
Analysis
Pasithea Therapeutics Corp. (KTTAW) Divestments (2022 - 2023) Analysis & Trends
Pasithea Therapeutics has disclosed Divestments across 2 years of filings, most recently posting $319618.0 for Q2 2023.
- In Q2 2023, Divestments rose 173.94% year-over-year to $319618.0; the TTM figure through Dec 2023 stood at $323807.0 (up 151.65% YoY), while the FY2023 annual figure was $323807.0, up 151.65% from the prior year.
- Divestments came in at $319618.0 for Q2 2023 at Pasithea Therapeutics, up from $4189.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $319618.0 in Q2 2023 to a low of -$432291.0 in Q2 2022.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 319,618.00 |
| Mar 31, 2023 | 4,189.00 |
| Dec 31, 2022 | 71,892.00 |
| Sep 30, 2022 | -159,955.00 |
| Jun 30, 2022 | -432,291.00 |
| Mar 31, 2022 | -106,544.00 |